Literature DB >> 26557727

THE EFFECT OF GLUCOCORTICOIDS ON BONE AND MUSCLE.

Gordon L Klein1.   

Abstract

This article examines the current knowledge of the effects of both exogenous and endogenous glucocorticoids on bone and muscle. It demonstrates the similarity of effects of supraphysiologic loads of glucocorticoids regardless of whether they enter the body in the form of medication or are manufactured by the body in response to stimuli such as inflammation. The effects of endogenous glucocorticoids and the systemic inflammatory response resulting from pediatric burn injury are compared and the difficulty in sorting out which of the two factors is responsible for the ultimate effects on bone and muscle is pointed out. The focus then switches to the body's response to the influence of both glucocorticoids and inflammatory cytokines and evidence supporting a common pathway of response to oxidative damage caused by both is discussed. Current recommended medical management of glucocorticoid-induced bone and muscle loss is discussed and the failure to reconcile current management with known mechanisms is highlighted.

Entities:  

Keywords:  bone; forkhead box O; glucocorticoids; muscle; oxidative stress

Year:  2015        PMID: 26557727      PMCID: PMC4635469          DOI: 10.1016/j.afos.2015.07.008

Source DB:  PubMed          Journal:  Osteoporos Sarcopenia        ISSN: 2405-5255


  42 in total

1.  Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle.

Authors:  Noriaki Shimizu; Noritada Yoshikawa; Naoki Ito; Takako Maruyama; Yuko Suzuki; Sin-ichi Takeda; Jun Nakae; Yusuke Tagata; Shinobu Nishitani; Kenji Takehana; Motoaki Sano; Keiichi Fukuda; Makoto Suematsu; Chikao Morimoto; Hirotoshi Tanaka
Journal:  Cell Metab       Date:  2011-02-02       Impact factor: 27.287

2.  Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection.

Authors:  M C Ruzek; B D Pearce; A H Miller; C A Biron
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

Review 3.  Use of oral corticosteroids and risk of fractures.

Authors:  T P Van Staa; H G Leufkens; L Abenhaim; B Zhang; C Cooper
Journal:  J Bone Miner Res       Date:  2000-06       Impact factor: 6.741

4.  Identification of microRNAs involved in dexamethasone-induced muscle atrophy.

Authors:  He Shen; Teng Liu; Liangliang Fu; Shuhong Zhao; Bin Fan; Jianhua Cao; Xinyun Li
Journal:  Mol Cell Biochem       Date:  2013-05-29       Impact factor: 3.396

5.  Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice.

Authors:  Zhaoyong Hu; Huiling Wang; In Hee Lee; Jie Du; William E Mitch
Journal:  J Clin Invest       Date:  2009-09-14       Impact factor: 14.808

6.  Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle.

Authors:  Theodore P Braun; Aaron J Grossberg; Stephanie M Krasnow; Peter R Levasseur; Marek Szumowski; Xin Xia Zhu; Julia E Maxson; J Gabriel Knoll; Anthony P Barnes; Daniel L Marks
Journal:  FASEB J       Date:  2013-06-03       Impact factor: 5.191

Review 7.  Glucocorticoids and the osteoclast.

Authors:  Hyun-Ju Kim; Haibo Zhao; Hideki Kitaura; Sandip Bhattacharyya; Judson A Brewer; Louis J Muglia; F Patrick Ross; Steven L Teitelbaum
Journal:  Ann N Y Acad Sci       Date:  2007-11       Impact factor: 5.691

8.  Preliminary evidence of early bone resorption in a sheep model of acute burn injury: an observational study.

Authors:  Gordon L Klein; Yixia Xie; Yi-Xian Qin; Liangjun Lin; Minyi Hu; Perenlei Enkhbaatar; Lynda F Bonewald
Journal:  J Bone Miner Metab       Date:  2013-06-20       Impact factor: 2.626

9.  FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation.

Authors:  Shoshana M Bartell; Ha-Neui Kim; Elena Ambrogini; Li Han; Srividhya Iyer; S Serra Ucer; Peter Rabinovitch; Robert L Jilka; Robert S Weinstein; Haibo Zhao; Charles A O'Brien; Stavros C Manolagas; Maria Almeida
Journal:  Nat Commun       Date:  2014-04-30       Impact factor: 14.919

10.  Myostatin suppression of Akirin1 mediates glucocorticoid-induced satellite cell dysfunction.

Authors:  Yanjun Dong; Jenny S Pan; Liping Zhang
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

View more
  22 in total

1.  The Association Between Polypharmacy and Physical Function in Older Adults: a Systematic Review.

Authors:  Andreas Katsimpris; Jacob Linseisen; Christa Meisinger; Konstantinos Volaklis
Journal:  J Gen Intern Med       Date:  2019-06-25       Impact factor: 5.128

2.  Sarcopenia is highly prevalent in children with autoimmune liver diseases and is linked to visceral fat and parent-perceived general health.

Authors:  Antoinette A Amevor; Toshifumi Yodoshi; Andrew T Trout; Jonathan R Dillman; Ruchi Singh; Ryan Jarvis; Lin Fei; Chunyan Liu; Amy Taylor; Alexander Miethke; Marialena Mouzaki
Journal:  Liver Int       Date:  2021-11-29       Impact factor: 8.754

Review 3.  Prevalence of Sarcopenia and its Association with Antirheumatic Drugs in Middle-Aged and Older Adults with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.

Authors:  Thang Dao; Ben Kirk; Steven Phu; Sara Vogrin; Gustavo Duque
Journal:  Calcif Tissue Int       Date:  2021-06-16       Impact factor: 4.333

Review 4.  Antioxidants in Sport Sarcopenia.

Authors:  Maria Michela Cesare; Francesca Felice; Veronica Santini; Rossella Di Stefano
Journal:  Nutrients       Date:  2020-09-19       Impact factor: 5.717

5.  Glucocorticoid use and complications following immune checkpoint inhibitor use in melanoma.

Authors:  Kapil Agarwal; Nadia Yousaf; Daniel Morganstein
Journal:  Clin Med (Lond)       Date:  2020-03       Impact factor: 2.659

6.  Growth recovery lines: a specific indicator of child abuse and neglect?

Authors:  Lora R Spiller; Nancy D Kellogg; Maria-Gisela Mercado-Deane; Anthony I Zarka; Jonathan A L Gelfond
Journal:  Pediatr Radiol       Date:  2019-09-14

7.  The Association of Mitochondrial Copy Number With Sarcopenia in Adult Survivors of Childhood Cancer.

Authors:  Kelly McCastlain; Carrie R Howell; Catherine E Welsh; Zhaoming Wang; Carmen L Wilson; Heather L Mulder; John Easton; Ann C Mertens; Jinghui Zhang; Yutaka Yasui; Melissa M Hudson; Leslie L Robison; Mondira Kundu; Kirsten K Ness
Journal:  J Natl Cancer Inst       Date:  2021-11-02       Impact factor: 13.506

Review 8.  Novel Insights into the Pathogenesis of Spinal Sarcopenia and Related Therapeutic Approaches: A Narrative Review.

Authors:  Yu-Kai Kuo; Yu-Ching Lin; Ching-Yu Lee; Chih-Yu Chen; Jowy Tani; Tsung-Jen Huang; Hsi Chang; Meng-Huang Wu
Journal:  Int J Mol Sci       Date:  2020-04-24       Impact factor: 5.923

9.  Short-term glucocorticoid excess blunts abaloparatide-induced increase in femoral bone mass and strength in mice.

Authors:  Mikkel Bo Brent; Jesper Skovhus Thomsen; Annemarie Brüel
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

10.  Why so little effort to study anti-oxidant therapy in burns?

Authors:  Gordon L Klein
Journal:  Burns Trauma       Date:  2016-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.